MTX: METHOTREXATE
MTX is a Ligand Of Interest in 2OIP designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 2OIP_MTX_A_605 | 59% | 22% | 0.181 | 0.963 | 1.38 | 1.87 | 3 | 10 | 4 | 0 | 100% | 1 |
| 2OIP_MTX_B_609 | 54% | 23% | 0.186 | 0.952 | 1.39 | 1.75 | 3 | 9 | 5 | 0 | 100% | 1 |
| 2OIP_MTX_D_617 | 43% | 23% | 0.211 | 0.934 | 1.35 | 1.8 | 2 | 9 | 5 | 0 | 100% | 1 |
| 2OIP_MTX_E_621 | 22% | 25% | 0.246 | 0.863 | 1.3 | 1.72 | 2 | 8 | 8 | 0 | 100% | 1 |
| 2OIP_MTX_C_613 | 18% | 25% | 0.268 | 0.854 | 1.32 | 1.72 | 2 | 8 | 4 | 0 | 100% | 1 |
| 6PFG_MTX_C_604 | 69% | 19% | 0.151 | 0.965 | 1.6 | 1.85 | 5 | 9 | 3 | 0 | 100% | 1 |
| 3HJ3_MTX_B_609 | 67% | 13% | 0.141 | 0.95 | 1.9 | 2.06 | 10 | 10 | 3 | 0 | 100% | 1 |
| 6PFE_MTX_E_604 | 61% | 16% | 0.166 | 0.956 | 1.93 | 1.76 | 4 | 8 | 2 | 0 | 100% | 1 |
| 6PFA_MTX_A_604 | 55% | 19% | 0.173 | 0.941 | 1.62 | 1.86 | 5 | 10 | 1 | 0 | 100% | 1 |
| 6PFI_MTX_A_604 | 54% | 18% | 0.182 | 0.949 | 1.63 | 1.88 | 5 | 9 | 2 | 0 | 100% | 1 |
| 1RA3_MTX_A_161 | 97% | 9% | 0.058 | 0.974 | 1.61 | 2.84 | 8 | 23 | 1 | 0 | 100% | 1 |
| 1U72_MTX_A_188 | 97% | 20% | 0.065 | 0.979 | 1.13 | 2.23 | 2 | 16 | 2 | 0 | 100% | 1 |
| 1RG7_MTX_A_161 | 94% | 7% | 0.071 | 0.968 | 1.88 | 2.93 | 9 | 17 | 1 | 0 | 100% | 1 |
| 1DDR_MTX_B_200 | 93% | 2% | 0.077 | 0.971 | 2.29 | 4.49 | 7 | 20 | 0 | 1 | 100% | 1 |
| 3QXT_MTX_A_2000 | 92% | 9% | 0.065 | 0.954 | 2.19 | 2.23 | 10 | 18 | 1 | 0 | 100% | 1 |
